Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Cbz-Tyr(Tf)-Bzl is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

257628-06-1

Post Buying Request

257628-06-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

257628-06-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 257628-06-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,7,6,2 and 8 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 257628-06:
(8*2)+(7*5)+(6*7)+(5*6)+(4*2)+(3*8)+(2*0)+(1*6)=161
161 % 10 = 1
So 257628-06-1 is a valid CAS Registry Number.

257628-06-1Downstream Products

257628-06-1Relevant articles and documents

The substrate-activity-screening methodology applied to receptor tyrosine kinases: A proof-of-concept study

Chapelat, Julien,Berst, Frédéric,Marzinzik, Andreas L.,Moebitz, Henrik,Drueckes, Peter,Trappe, Joerg,Fabbro, Doriano,Seebach, Dieter

supporting information, p. 1 - 9 (2013/01/15)

Protein kinases are widely recognized as important therapeutic targets due to their involvement in signal transduction pathways. These pathways are tightly controlled and regulated, notably by the ability of kinases to selectively phosphorylate a defined set of substrates. A wide variety of disorders can arise as a consequence of abnormal kinase-mediated phosphorylation and numerous kinase inhibitors have earned their place as key components of the modern pharmacopeia. Although "traditional" kinase inhibitors typically act by preventing the interaction between the kinase and ATP, thus stopping substrate phosphorylation, an alternative approach consists in disrupting the protein-protein interaction between the kinase and its downstream partners. In order to facilitate the identification of potential chemical starting points for substrate-site inhibition approaches, we desired to investigate the application of Substrate Activity Screening to kinases. We herein report a proof-of-concept study demonstrating, on a model tyrosine kinase, that the key requirements of this methodology can be met. Namely, using peptides as model substrates, we show that a simple ADP-accumulation assay can be used to monitor substrate efficiency and that efficiency can be optimized in a modular manner. More importantly, we demonstrate that structure-efficiency relationships translate into structure-activity relationships upon conversion of the substrates into inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 257628-06-1